These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24305980)

  • 1. Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer.
    Liu Y; Zhou R; Baumbusch LO; Tsavachidis S; Brewster AM; Do KA; Sahin A; Hortobagyi GN; Taube JH; Mani SA; Aarøe J; Wärnberg F; Børresen-Dale AL; Mills GB; Thompson PA; Bondy ML
    Breast Cancer Res Treat; 2014 Jan; 143(1):189-201. PubMed ID: 24305980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer.
    Thompson PA; Brewster AM; Kim-Anh D; Baladandayuthapani V; Broom BM; Edgerton ME; Hahn KM; Murray JL; Sahin A; Tsavachidis S; Wang Y; Zhang L; Hortobagyi GN; Mills GB; Bondy ML
    PLoS One; 2011; 6(8):e23543. PubMed ID: 21858162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis.
    Pavlovic M; Arnal-Estapé A; Rojo F; Bellmunt A; Tarragona M; Guiu M; Planet E; Garcia-Albéniz X; Morales M; Urosevic J; Gawrzak S; Rovira A; Prat A; Nonell L; Lluch A; Jean-Mairet J; Coleman R; Albanell J; Gomis RR
    J Natl Cancer Inst; 2015 Dec; 107(12):djv256. PubMed ID: 26376684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copy number imbalances between screen- and symptom-detected breast cancers and impact on disease-free survival.
    Brewster AM; Thompson P; Sahin AA; Do K; Edgerton M; Murray JL; Tsavachidis S; Zhou R; Liu Y; Zhang L; Mills G; Bondy M
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1609-16. PubMed ID: 21795423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal imbalances are associated with metastasis-free survival in breast cancer patients.
    Aubele M; Auer G; Braselmann H; Nährig J; Zitzelsberger H; Quintanilla-Martinez L; Smida J; Walch A; Höfler H; Werner M
    Anal Cell Pathol; 2002; 24(2-3):77-87. PubMed ID: 12446957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer.
    Jung SH; Lee A; Yim SH; Hu HJ; Choe C; Chung YJ
    BMC Cancer; 2012 Aug; 12():382. PubMed ID: 22938721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis.
    Valla M; Engstrøm MJ; Ytterhus B; Hansen ÅK; Akslen LA; Vatten LJ; Opdahl S; Bofin AM
    Breast Cancer Res Treat; 2017 Apr; 162(2):243-253. PubMed ID: 28124285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-level expression of CXCR4 in breast cancer is associated with early distant and bone metastases.
    Hung CS; Su HY; Liang HH; Lai CW; Chang YC; Ho YS; Wu CH; Ho JD; Wei PL; Chang YJ
    Tumour Biol; 2014 Feb; 35(2):1581-8. PubMed ID: 24101191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
    Diessner J; Wischnewsky M; Stüber T; Stein R; Krockenberger M; Häusler S; Janni W; Kreienberg R; Blettner M; Schwentner L; Wöckel A; Bartmann C
    BMC Cancer; 2016 May; 16():307. PubMed ID: 27175930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
    Li X; Zhang X; Liu J; Shen Y
    BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark.
    Cronin-Fenton D; Kjærsgaard A; Nørgaard M; Amelio J; Liede A; Hernandez RK; Sørensen HT
    Breast Cancer Res Treat; 2018 Jan; 167(2):517-528. PubMed ID: 28948396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.
    Liu J; Sieuwerts AM; Look MP; van der Vlugt-Daane M; Meijer-van Gelder ME; Foekens JA; Hollestelle A; Martens JW
    PLoS One; 2016; 11(8):e0161731. PubMed ID: 27552096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
    Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
    BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological factors associated with survival in patients with breast cancer brain metastasis.
    Li R; Zhang K; Siegal GP; Wei S
    Hum Pathol; 2017 Jun; 64():53-60. PubMed ID: 28428107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas.
    Alarmo EL; Korhonen T; Kuukasjärvi T; Huhtala H; Holli K; Kallioniemi A
    Ann Oncol; 2008 Feb; 19(2):308-14. PubMed ID: 17895257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral bisphosphonates for osteoporosis on development of skeletal metastases in women with breast cancer: results from a pharmaco-epidemiological study.
    Kremer R; Gagnon B; Meguerditchian AN; Nadeau L; Mayo N
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25278509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.
    Kawaguchi T; Yan L; Qi Q; Peng X; Edge SB; Young J; Yao S; Liu S; Otsuji E; Takabe K
    Ann Surg Oncol; 2018 Dec; 25(13):4037-4046. PubMed ID: 30311168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline DNA copy number aberrations identified as potential prognostic factors for breast cancer recurrence.
    Sapkota Y; Ghosh S; Lai R; Coe BP; Cass CE; Yasui Y; Mackey JR; Damaraju S
    PLoS One; 2013; 8(1):e53850. PubMed ID: 23342018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRPS23 amplification and gene expression in breast cancer; association with proliferation and the non-basal subtypes.
    Klæstad E; Opdahl S; Engstrøm MJ; Ytterhus B; Wik E; Bofin AM; Valla M
    Breast Cancer Res Treat; 2020 Feb; 180(1):73-86. PubMed ID: 31950385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of early distant metastasis in women with breast cancer.
    Rosa Mendoza ES; Moreno E; Caguioa PB
    J Cancer Res Clin Oncol; 2013 Apr; 139(4):645-52. PubMed ID: 23283528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.